|
|
Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target
Rémi Legastelois
,
Jérôme Jeanblanc
,
Catherine Vilpoux
,
Erika Bourguet
,
Mickaël Naassila
Article dans une revue
istex
hal-01929543v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Simultaneous presence of unsatuation and long alkyl chain at P'1 of ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9= inhibition as shown by molecular modelling studies
Gauthier Moroy
,
Clément Denhez
,
Haquima El Mourabit
,
Alix Toribio
,
Alexandra Dassonville
,
et al.
Bioorganic and Medicinal Chemistry, 2007, 15, pp.4753-4766
Article dans une revue
hal-00157962v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Neutrophil elastase as a target in lung cancer.
Gautier Moroy
,
Alix Aj
,
J. Sapi
,
W. Hornebeck
,
E. Bourguet
Anti-Cancer Agents in Medicinal Chemistry, 2012, 12 (6), pp.565-579
Article dans une revue
hal-00717313v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Looking forward : a glance into the future of organic chemistry
Philippe Compain
,
Valérie Desvergnes
,
Cyril Ollivier
,
Frédéric Robert
,
Franck Suzenet
,
et al.
Article dans une revue
istex
hal-00158370v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
How could histone deacetylase activators be useful leads in the search for new therapeutics?
Erika Bourguet
,
Mickaël Naassila
Article dans une revue
hal-02429347v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Class I HDAC Inhibitors: Potential New Epigenetic Therapeutics for Alcohol Use Disorder (AUD)
Erika Bourguet
,
Katarzyna Ozdarska
,
Gautier Moroy
,
Jérôme Jeanblanc
,
Mickaël Naassila
Article dans une revue
hal-01929517v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Unexpected effect of cyclodepsipeptides bearing a sulfonylhydrazide moiety towards histone deacetylase activity
Mathieu Létévé
,
Céline Gonzalez
,
Gautier Moroy
,
Agathe Martinez
,
Jérôme Jeanblanc
,
et al.
Article dans une revue
hal-01929527v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Interest of new alkylsulfonylhydrazide-type compound in the treatment of alcohol use disorders
Jérôme Jeanblanc
,
Erika Bourguet
,
Diana Sketriene
,
Céline Gonzalez
,
Gautier Moroy
,
et al.
Article dans une revue
hal-01929565v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Introduction of the 4-(4 bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity
G. Ledour
,
Gautier Moroy
,
M. Rouffet
,
E. Bourguet
,
D. Guillaume
,
et al.
Bioorganic and Medicinal Chemistry, 2008, 16 (18), pp.8745-8759
Article dans une revue
hal-00345606v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Control of melanoma invasiveness by anticollagenolytic agents : a Reappraisal of an old concept.
E. Bourguet
,
J. Sapi
,
H. Emonard
,
W. Hornebeck
Anti-Cancer Agents in Medicinal Chemistry, 2009, 9 (3), pp.576-597
Article dans une revue
hal-00395923v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Synthesis and conformational studies of pseudopeptides containing an unsymmetrical triazine scaffold
Erika Bourguet
,
Isabelle Correia
,
Bertrand Dorgeret
,
Gérard Chassaing
,
Sames Sicsic
,
et al.
Article dans une revue
hal-02465291v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Design, Synthesis, and Use of MMP-2 Inhibitor-Conjugated Quantum Dots in Functional Biochemical Assays
Erika Bourguet
,
Kristina Brazhnik
,
Alyona Sukhanova
,
Gautier Moroy
,
Sylvie Brassart-Pasco
,
et al.
Article dans une revue
hal-01929576v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Inhibition of human leukocyte elastase, plasmin and matrix metalloproteinases by oleic acid and oleoyl-galardin derivatives(s).
Gautier Moroy
,
E. Bourguet
,
M. Decarme
,
J. Sapi
,
Alix A.J.P.
,
et al.
Article dans une revue
istex
hal-00583323v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Future alchemy: account of the ESYOP experiment
Philippe Compain
,
Valérie Desvergnes
,
Cyril Ollivier
,
Frédéric Robert
,
Franck Suzenet
,
et al.
Article dans une revue
hal-00158010v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|